Electrospray Ionization Mass Spectrometry (ESI-MS) combined with specialized trial mass tags enables precise characterization, quantification, and structural verification of synthetic peptides in the 2400 Da molecular weight range. For laboratory researchers evaluating analytical purity and sequence integrity, understanding multi-charge state distributions and isotope labeling mechanisms is essential for rigorous in vitro research.
Electrospray Ionization Mass Spectrometry (ESI-MS) combined with specialized trial mass tags enables precise characterization, quantification, and structural verification of synthetic peptides in the 2400 Da molecular weight range. For laboratory researchers evaluating analytical purity and sequence integrity, understanding multi-charge state distributions and isotope labeling mechanisms is essential for rigorous in vitro research.
Electrospray Ionization Mass Spectrometry (ESI-MS) serves as the benchmark methodology for structural confirmation and mass identification of synthetic macromolecules. When applied to research peptides with a molecular mass around 2400 Da, ESI-MS provides soft ionization that yields intact multivalent ions, such as [M+2H]2+ and [M+3H]3+ species. This soft ionization preserves sensitive amino acid side-chain modifications and attached chemical moieties.
In quantitative and qualitative proteomics, trial tags—often synthesized as isobaric tags, isotopic labels, or fluorophore-mass tag conjugates—are introduced into a peptide sequence to monitor receptor binding kinetics, enzymatic cleavage, or cellular uptake in preclinical models. Interpreting ESI-MS spectra for tagged peptides around 2400 Da requires precise deconvolution of isotopic envelopes, charge-state distributions, and mass-to-charge (m/z) ratios under defined chromatographic conditions. Researchers can explore PX1's full inventory of analytical compounds within our all peptides catalog.
ESI-MS operates by converting liquid-phase analyte ions into gas-phase ions via an atmospheric pressure electrospray interface. The sample solution, containing the synthetic compound dissolved in an organic-aqueous carrier solvent (typically water/acetonitrile with 0.1% formic acid), is passed through a micro-capillary held at high voltage (2.5 to 4.0 kV).
As charged droplets desolvate under a thermal nitrogen drying gas curtain, Coulombic repulsion forces cause droplet fission (the Rayleigh limit). This process yields naked, highly charged peptide ions that enter the high-vacuum analyzer of quadrupole, time-of-flight (TOF), or Orbitrap instruments. For peptides near 2400 Da, ESI characteristically generates prominent doubly ([M+2H]2+, m/z ~1201) and triply ([M+3H]3+, m/z ~801) charged precursor ions, allowing ultra-high-resolution mass determination without thermal degradation. For detailed technical literature on analytical methods, visit the PX1 research library.
Trial tags—frequently integrated during solid-phase peptide synthesis (SPPS)—serve as specific chemical handles, mass markers, or spectroscopic reporters. These tags alter the native molecular mass of a peptide sequence by a predicted dalton increment, enabling multiplexed assay design and distinct mass spectral signatures.
Common trial tags include N-terminal biotinylation, fluorescent dyes (e.g., FITC, Cy5), stable isotope labels (13C, 15N), or reactive amine-specific isobaric mass tags. In a 2400 Da peptide construct, adding a chemical tag alters hydrophobic interaction during Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and modifies the overall ionization efficiency during ESI-MS profiling. Ensuring that trial tags remain covalently attached and stable during acidic cleavage and purification is critical for consistent assay reproducibility.
Interpreting the ESI-MS output for a 2400 Da tagged compound involves examining both the theoretical exact mass and the observed mass-to-charge ratios across multiple charge envelopes. Because peptides of this mass contain a natural distribution of heavy stable isotopes (primarily 13C, 15N, and 18O), the monoisotopic peak must be carefully distinguished from the average isotopic mass.
When analyzing high-resolution ESI-TOF or Orbitrap data, the monoisotopic mass corresponds to the ion composed entirely of the most abundant isotopes (e.g., 12C, 1N, 16O, 1H). For a representative 2400.2 Da compound, the monoisotopic [M+2H]2+ ion appears at m/z 1201.107, accompanied by an isotope distribution spaced at Δm/z = 0.5 Da intervals. High-purity compounds exhibit sharp, monodisperse signals without truncated sequence fragments or adduct ions (such as [M+Na]+ or [M+K]+), which can distort spectral quantification.
Peptides falling within the 2000 to 3000 Da mass range—including tagged therapeutic analogs and receptor agonists—are routinely utilized in cell culture models, competitive binding assays, and enzymatic resistance studies. The inclusion of trial tags allows researchers to track receptor internalization via mass spectrometry-based targeted assays (MRM/PRM) or fluorescence microscopy.
In vitro data indicate that tagged peptides within this molecular weight class provide structural stability while mimicking endogenous ligand interactions. For instance, in preclinical cell line experiments, tagged target analogs are exposed to plasma proteases to monitor sequence degradation rates via time-course ESI-MS sampling. Maintaining verified chemical purity ensures that experimental results reflect true ligand-receptor dynamics rather than artifacts caused by synthesis byproducts or salt contaminants.
In analytical spectroscopy, comparing structural properties across distinct molecular weight classes aids in method optimization and LC-MS method development. Synthetic peptides vary significantly in their ionization tendencies and charge-state envelopes depending on primary sequence length and chemical functionalization.
For example, medium-chain research compounds like cjc-1295-dac (MW ~3647 Da) display higher charge states ([M+4H]4+, [M+5H]5+) and extended retention times on C18 columns compared to 2400 Da tagged structures. Conversely, smaller pentadecapeptides such as bpc-157 (MW ~1419 Da) typically ionize predominantly as singly or doubly charged species ([M+H]+, [M+2H]2+). Specialized multi-target constructs such as tirzepatide (MW ~4813 Da) exhibit complex isotopic envelopes requiring specialized organic solvent gradients for optimal ESI-MS desolvation.
Proper reconstitution of lyophilized 2400 Da tagged peptides is essential to preserve secondary structure and prevent aggregation prior to ESI-MS analysis. Lyophilized cakes should be allowed to equilibrate to room temperature in a desiccator before opening the vial to prevent condensation uptake.
Reconstitution protocols recommend dissolving the research compound in sterile laboratory-grade water or dilute organic-aqueous buffers (such as 0.1% acetic acid or 10% acetonitrile) depending on the hydropathic index of the sequence. Sonication should be avoided as it may cause mechanical shear or cleavage of labile trial tags. Once reconstituted, aliquot the solution into inert, low-binding micro-centrifuge tubes and store at -80°C to minimize freeze-thaw degradation cycles.
To guarantee experimental reproducibility in laboratory research, investigators must source research compounds backed by comprehensive analytical validation. Every batch of peptide produced for laboratory use must undergo rigorous characterization, including analytical Reverse-Phase HPLC to establish chemical purity (≥98%) and ESI-MS to confirm exact molecular mass.
PX1 Research enforces strict quality assurance protocols. All products are manufactured in GMP-compliant facilities within the USA and tested by an independent, ISO 17025 accredited analytical laboratory. Each lot includes a lot-specific Certificate of Analysis (COA) displaying raw HPLC chromatograms and full ESI-MS mass spectra. For high-volume research institutions requiring lot-to-lot consistency, explore our wholesale research accounts.
In addition to chemical purity and mass verification, controlling bacterial endotoxin contamination is vital for sensitive in vitro tissue assays and cell culture models. Lipopolysaccharides (LPS) present in unrefined peptide preparations can induce false immunological responses, obscuring experimental readouts.
PX1 Research conducts Chromogenic Reagent (LAL) testing on every lot to ensure endotoxin levels remain below strictly defined laboratory limits (<0.01 EU/µg). Combined with state-of-the-art ESI-MS verification and US-based storage facilities in California and Arizona, researchers receive validated, ultra-pure compounds shipped same-day (Monday–Friday) for uninterrupted experimental workflows.
What is ESI-MS and how is it used to verify 2400 Da research peptides?
ESI-MS (Electrospray Ionization Mass Spectrometry) is a soft ionization analytical technique that converts liquid peptide samples into gas-phase ions. For a ~2400 Da peptide, ESI-MS measures intact multivalent ions (such as doubly and triply charged species), providing exact molecular mass confirmation and identifying impurities without destroying the peptide structure.
What are trial tags in peptide synthesis and laboratory assays?
Trial tags are chemical modifications, mass labels, stable isotopes, or fluorescent markers attached to a synthetic peptide sequence during or after synthesis. They allow researchers to trace, quantify, or isolate the peptide in complex in vitro assays, cellular binding studies, and LC-MS workflows.
Why do ESI-MS spectra show multiple peaks for a single 2400 Da compound?
Multiple peaks occur due to multi-charging phenomena ([M+2H]2+, [M+3H]3+) characteristic of electrospray ionization, as well as the natural isotopic distribution of carbon, nitrogen, and oxygen atoms (such as 13C and 15N) present in a 2400 Da macromolecule.
Are PX1 Research compounds tested for analytical purity?
Yes. Every lot supplied by PX1 Research undergoes third-party analytical testing at an ISO 17025 accredited laboratory. Each compound includes a downloadable Certificate of Analysis (COA) detailing RP-HPLC purity (typically ≥98%), ESI-MS mass confirmation, and endotoxin levels.
How should a lyophilized 2400 Da tagged peptide be stored upon receipt?
Lyophilized compounds should be stored at -20°C or -80°C in a dry environment away from light. Prior to reconstitution, vials should reach room temperature to prevent moisture condensation inside the container.
What solvent is recommended for reconstituting tagged peptides for ESI-MS?
Reconstitution depends on sequence hydrophobicity, but standard laboratory protocols utilize LC-MS grade water, 0.1% formic acid, or low-percentage acetonitrile solutions. Avoid volatile buffers that contain non-volatile salts (such as PBS) when preparing samples directly for ESI-MS analysis.
Are PX1 products suitable for human administration or clinical use?
No. All products offered by PX1 Research are strictly intended for laboratory in vitro and preclinical research use only. They are not for human consumption, clinical trials, or therapeutic applications.
Where are PX1 Research compounds manufactured and shipped from?
PX1 Research peptides are synthesized in GMP-compliant facilities in the United States and shipped directly from our primary distribution hubs in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.